Synthetic cannabinoids are far more potent and dangerous than natural cannabis, with 207 compounds identified in Europe
Synthetic cannabinoids, sold as "Spice" or "K2," act as full receptor agonists making them much more potent than natural cannabis, with documented renal, respiratory, cardiovascular, and neurological toxicity including death.
Quick Facts
What This Study Found
207 synthetic cannabinoid compounds were identified by the EMCDDA from 2008 to 2020. As full CB receptor agonists, they are much more potent than natural cannabis (a partial agonist). Documented toxicity includes renal damage, respiratory depression, cardiovascular effects, hyperemesis, and neurotoxicity. Some have been classified as Schedule 1.
Key Numbers
207 synthetic compounds identified by EMCDDA (2008-2020); 9 new compounds reported in latest period; sold as Spice, K2, Black Mamba, Bombay Blue; act as full agonists vs partial agonism of natural THC
How They Did This
Review of the development, abuse patterns, and toxicological effects of synthetic cannabinoids, drawing on EMCDDA surveillance data and clinical reports.
Why This Research Matters
Synthetic cannabinoids are cheap, widely available, and often undetectable on standard drug tests. Their extreme potency compared to natural cannabis means users face far greater risks of acute toxicity and death.
The Bigger Picture
The rapid evolution of synthetic cannabinoids, with new analogues constantly created to evade regulation, represents one of the most dangerous developments in the recreational drug landscape.
What This Study Doesn't Tell Us
Review cannot cover all 207+ compounds in detail. Toxicity data varies by compound. Many adverse events likely go unreported. The rapid emergence of new analogues means the review may already be outdated.
Questions This Raises
- ?Can regulation keep pace with the creation of new synthetic cannabinoid analogues?
- ?Would wider access to legal cannabis reduce demand for synthetics?
- ?What are the long-term effects of synthetic cannabinoid exposure?
Trust & Context
- Key Stat:
- 207 different synthetic cannabinoids identified in Europe since 2008
- Evidence Grade:
- Review based on EMCDDA surveillance data and clinical toxicology reports
- Study Age:
- Published in 2021. New synthetic cannabinoid compounds continue to emerge regularly.
- Original Title:
- Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health.
- Published In:
- Pharmaceuticals (Basel, Switzerland), 14(10) (2021)
- Authors:
- Bukke, Vidyasagar Naik, Archana, Moola, Villani, Rosanna, Serviddio, Gaetano, Cassano, Tommaso
- Database ID:
- RTHC-03031
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
How are synthetic cannabinoids different from natural cannabis?
Natural THC is a partial agonist at CB receptors. Synthetic cannabinoids are full agonists, making them much more potent with higher risk of severe adverse effects including organ damage and death.
What are the dangers of synthetic cannabinoids?
Documented effects include renal toxicity, respiratory depression, cardiovascular problems, hyperemesis, and neurotoxicity. Over 207 different compounds have been identified, making them unpredictable and difficult to treat in overdose.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- THC-purity-potency-label-meaning
- cannabis-relapse-cycle-pattern
- cold-turkey-vs-taper-quit-weed
- dab-concentrate-addiction-withdrawal
- dating-sober-after-quitting-weed
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- healthiest-way-to-consume-cannabis
- help-someone-quit-weed
- how-cannabis-products-made-concentrates-edibles
- how-to-quit-weed
- journaling-weed-withdrawal
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- sativa-vs-indica-difference-myth
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-potency-withdrawal
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-03031APA
Bukke, Vidyasagar Naik; Archana, Moola; Villani, Rosanna; Serviddio, Gaetano; Cassano, Tommaso. (2021). Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health.. Pharmaceuticals (Basel, Switzerland), 14(10). https://doi.org/10.3390/ph14100965
MLA
Bukke, Vidyasagar Naik, et al. "Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health.." Pharmaceuticals (Basel, 2021. https://doi.org/10.3390/ph14100965
RethinkTHC
RethinkTHC Research Database. "Pharmacological and Toxicological Effects of Phytocannabinoi..." RTHC-03031. Retrieved from https://rethinkthc.com/research/bukke-2021-pharmacological-and-toxicological-effects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.